Cargando…

A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel Ube3a mutants

BACKGROUND: Angelman syndrome (AS) is a neurodevelopmental disorder caused by mutations affecting UBE3A function. AS is characterized by intellectual disability, impaired motor coordination, epilepsy, and behavioral abnormalities including autism spectrum disorder features. The development of treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sonzogni, Monica, Wallaard, Ilse, Santos, Sara Silva, Kingma, Jenina, du Mee, Dorine, van Woerden, Geeske M., Elgersma, Ype
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137919/ https://www.ncbi.nlm.nih.gov/pubmed/30220990 http://dx.doi.org/10.1186/s13229-018-0231-7

Ejemplares similares

Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome
por: Sonzogni, Monica, et al.
Publicado: (2020)

UBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome
por: Elgersma, Ype, et al.
Publicado: (2021)

Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes
por: Sonzogni, Monica, et al.
Publicado: (2019)

Adult Camk2a gene reinstatement restores the learning and plasticity deficits of Camk2a knockout mice
por: Rigter, Pomme M.F., et al.
Publicado: (2022)

Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse model
por: Milazzo, Claudia, et al.
Publicado: (2021)

Enhanced Transmission at the Calyx of Held Synapse in a Mouse Model for Angelman Syndrome
por: Wang, Tiantian, et al.
Publicado: (2018)

Multidimensional analysis of behavior predicts genotype with high accuracy in a mouse model of Angelman syndrome
por: Tanas, Joseph K., et al.
Publicado: (2022)

UBE3A expression during early postnatal brain development is required for proper dorsomedial striatal maturation
por: Rotaru, Diana C., et al.
Publicado: (2023)

Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations
por: Bossuyt, Stijn N V, et al.
Publicado: (2021)

The role of ubiquitin ligase E3A in polarized contact guidance and rescue strategies in UBE3A-deficient hippocampal neurons
por: Tonazzini, Ilaria, et al.
Publicado: (2019)

Dual-isoform hUBE3A gene transfer improves behavioral and seizure outcomes in Angelman syndrome model mice
por: Judson, Matthew C., et al.
Publicado: (2021)

From first report to clinical trials: a bibliometric overview and visualization of the development of Angelman syndrome research
por: Zampeta, F. Isabella, et al.
Publicado: (2022)

Conserved UBE3A subcellular distribution between human and mice is facilitated by non-homologous isoforms
por: Zampeta, F Isabella, et al.
Publicado: (2020)

Secreted retrovirus-like GAG-domain-containing protein PEG10 is regulated by UBE3A and is involved in Angelman syndrome pathophysiology
por: Pandya, Nikhil J., et al.
Publicado: (2021)

A novel UBE3A sequence variant identified in eight related individuals with neurodevelopmental delay, results in a phenotype which does not match the clinical criteria of Angelman syndrome
por: Geerts‐Haages, Amber, et al.
Publicado: (2020)

From UBE3A to Angelman syndrome: a substrate perspective
por: Sell, Gabrielle L., et al.
Publicado: (2015)

The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome
por: Viho, Eva M. G., et al.
Publicado: (2022)

Clinical aspects of a large group of adults with Angelman syndrome
por: den Besten, Inge, et al.
Publicado: (2020)

Calmodulin kinase II regulates amphetamine-induced reverse transport in the dopamine transporter: implications for the importance of the dopamine transporter in Angelman syndrome
por: Steinkellner, Thomas, et al.
Publicado: (2010)

Identifying the temporal electrophysiological and molecular changes that contribute to TSC-associated epileptogenesis
por: Koene, Linda M.C., et al.
Publicado: (2021)

Distinct roles of α- and βCaMKII in controlling long-term potentiation of GABA(A)-receptor mediated transmission in murine Purkinje cells
por: Gao, Zhenyu, et al.
Publicado: (2014)

Angelman syndrome-associated ubiquitin ligase UBE3A/E6AP mutants interfere with the proteolytic activity of the proteasome
por: Tomaić, V, et al.
Publicado: (2015)

Early Origin and Evolution of the Angelman Syndrome Ubiquitin Ligase Gene Ube3a
por: Sato, Masaaki
Publicado: (2017)

Strain-dependence of the Angelman Syndrome phenotypes in Ube3a maternal deficiency mice
por: Born, Heather A., et al.
Publicado: (2017)

Hyperphagia, Growth, and Puberty in Children with Angelman Syndrome
por: Bindels-de Heus, Karen G. C. B., et al.
Publicado: (2023)

Truncation of Ube3a-ATS Unsilences Paternal Ube3a and Ameliorates Behavioral Defects in the Angelman Syndrome Mouse Model
por: Meng, Linyan, et al.
Publicado: (2013)

Angelman syndrome-derived neurons display late onset of paternal UBE3A silencing
por: Stanurova, Jana, et al.
Publicado: (2016)

Persistent neuronal Ube3a expression in the suprachiasmatic nucleus of Angelman syndrome model mice
por: Jones, Kelly A., et al.
Publicado: (2016)

The molecular, temporal and region-specific requirements of the beta isoform of Calcium/Calmodulin-dependent protein kinase type 2 (CAMK2B) in mouse locomotion
por: Kool, Martijn J., et al.
Publicado: (2016)

Corrigendum: Angelman syndrome-derived neurons display late onset of paternal UBE3A silencing
por: Stanurova, Jana, et al.
Publicado: (2018)

Deleting a UBE3A substrate rescues impaired hippocampal physiology and learning in Angelman syndrome mice
por: Sell, Gabrielle L., et al.
Publicado: (2021)

The role of whole exome sequencing in the UBE3A point mutation of Angelman Syndrome: A case report
por: Triono, Agung, et al.
Publicado: (2021)

Angelman Syndrome Protein Ube3a Regulates Synaptic Growth and Endocytosis by Inhibiting BMP Signaling in Drosophila
por: Li, Wenhua, et al.
Publicado: (2016)

Longitudinal EEG model detects antisense oligonucleotide treatment effect and increased UBE3A in Angelman syndrome
por: Spencer, Elizabeth R., et al.
Publicado: (2022)

Generation and Characterization of a Novel Angelman Syndrome Mouse Model with a Full Deletion of the Ube3a Gene
por: Syding, Linn Amanda, et al.
Publicado: (2022)

Effects of antiepileptic drugs in a new TSC/mTOR‐dependent epilepsy mouse model
por: Koene, Linda M. C., et al.
Publicado: (2019)

An overview of health issues and development in a large clinical cohort of children with Angelman syndrome
por: Bindels‐de Heus, Karen G. C. B., et al.
Publicado: (2019)

Evaluation of a TrkB agonist on spatial and motor learning in the Ube3a mouse model of Angelman syndrome
por: Schultz, Maria N., et al.
Publicado: (2020)

Protein Delivery of an Artificial Transcription Factor Restores Widespread Ube3a Expression in an Angelman Syndrome Mouse Brain
por: Bailus, Barbara J, et al.
Publicado: (2016)

Excessive Laughter-like Vocalizations, Microcephaly, and Translational Outcomes in the Ube3a Deletion Rat Model of Angelman Syndrome
por: Berg, Elizabeth L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_333vj61eo3fu87ksg9b9err7e3